Advancing Access to Better Patient Care

WORK – Past/Current

Our wealth of experience can support you across a range of HEOR, pricing and reimbursement strategy development.


Development of a U.S. HEOR, Evidence and Market Access Strategy for Single Use

  • Raising awareness on the clinical risks of cross- contamination and infection today in reusable scopes
  • Development of a U.S. market pricing, coding, reimbursement and Health Policy Dossier development. (Ambu)

Type 1 Diabetes Emerging Therapies Commercial Strategy Platform

Multi-Stakeholder exploration of the areas of unmet needs in the Type 1 Diabetes journey and how a range of emerging therapies may address these gaps. (Sanofi)

Additional Work